"The UK is not to blame. The EU is not to blame," said an EU
official. "It's about everyone finding agreement with a company that
has been over-selling its production capacity. AstraZeneca has to
deliver doses to its EU customers."
After falling far behind post-Brexit Britain and the United States
in rolling out vaccines, the EU's leaders are due to discuss
imposing a ban on vaccine exports to Britain at a summit on
Thursday.
British Prime Minister Boris Johnson is expected to speak to the
EU's most powerful leaders, German Chancellor Angela Merkel and
French President Emmanuel Macron, in a bid to get the bloc to steer
away from bans.
"There will continue to be some robust conversations with the
European Union about the importance of no such blockings happening,"
Helen Whately, a junior health minister, told LBC radio. "It's
really important that companies are able to fulfil their contractual
obligations."
Britain, which exited the EU's orbit on Dec. 31, has repeatedly
cautioned the EU that breaking contract law could have grave
consequences but has not yet specified what those consequences would
be.
AstraZeneca has told Brussels that the UK is using a clause in its
supply contract that prevents exports of its vaccines until the
British market is fully served, EU officials said.
While France, Germany and Italy broadly support tighter export curbs
on those who do not reciprocate, countries including the
Netherlands, Belgium and Ireland are more cautious about cutting off
the UK.
[to top of second column] |
The EU has so far blocked one
shipment of vaccines to Australia.
An EU official told Reuters on Sunday that the
bloc was rebuffing British government calls to
ship AstraZeneca COVID-19 vaccines produced in a
factory in the Netherlands.
"The Brits are insisting that the Halix plant in
the Netherlands must deliver the drug substance
produced there to them. That doesn't work," the
official told Reuters. The
Leiden-based plant, run by sub-contractor Halix, is listed as a
supplier of vaccines in both the contracts that AstraZeneca has
signed with Britain and with the European Union.
"What is produced in Halix has to go to the EU," the official added.
AstraZeneca has not yet sought approval in the EU for Halix, but the
official and a second EU source said the request was on its way.
Without regulatory approval, vaccines produced at Halix cannot be
used in the EU.
As of March 20, the UK had administered nearly 44 vaccines for every
100 people, whereas the EU had administered nearly 13 shots per 100
people, according to public data compiled by Our World In Data
website.
(Reporting by Paul Sandle in Londion and John Chalmers in Brussels;
Additional reporting by Sarah Young in London; Writing by Guy
Faulconbridge; Editing by Nick Macfie)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |